Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenelle Foote

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
BJU International|February 12, 2005
An investigation of dose titration with darifenacin, an M3-selective receptor antagonistWilliam Steers, Jacques Corcos, Jenelle Foote, et al.
International Urogynecology Journal|October 19, 2011
Time-to-effect with darifenacin in overactive bladder: a pooled analysisVik Khullar, Jenelle Foote, Yodit Seifu, et al.
The Journal of Family Practice|July 1, 2022
62-year-old woman • dysuria • dyspareunia • urinary incontinence • Dx?Folashade Omole, Ngozi F Anachebe, Dolapo Babalola, et al.
European Urology|July 2, 2005
Treatment of overactive bladder in the older patient: pooled analysis of three phase III studies of darifenacin, an M3 selective receptor antagonistJenelle Foote, Karin Glavind, Georg Kralidis, et al.
The Journal of Urology|December 13, 2002
Puboprostatic sling repair for treatment of urethral incompetence in adult neurogenic incontinenceSiamak Daneshmand, David A Ginsberg, James K Bennet, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
BJU International|February 12, 2005
An investigation of dose titration with darifenacin, an M3-selective receptor antagonistWilliam Steers, Jacques Corcos, Jenelle Foote, et al.
International Urogynecology Journal|October 19, 2011
Time-to-effect with darifenacin in overactive bladder: a pooled analysisVik Khullar, Jenelle Foote, Yodit Seifu, et al.
The Journal of Family Practice|July 1, 2022
62-year-old woman • dysuria • dyspareunia • urinary incontinence • Dx?Folashade Omole, Ngozi F Anachebe, Dolapo Babalola, et al.
European Urology|July 2, 2005
Treatment of overactive bladder in the older patient: pooled analysis of three phase III studies of darifenacin, an M3 selective receptor antagonistJenelle Foote, Karin Glavind, Georg Kralidis, et al.
The Journal of Urology|December 13, 2002
Puboprostatic sling repair for treatment of urethral incompetence in adult neurogenic incontinenceSiamak Daneshmand, David A Ginsberg, James K Bennet, et al.
Pageof 1